"Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to ..."

Elizabeth Lamont et al. (2016)

> Home

Details and statistics

DOI: —

access: closed

type: Conference or Workshop Paper

metadata version: 2024-04-17

- view
  - electronic edition @ amia.org (archived)
- export record
  dblp key:
  - conf/amia/LamontKAL16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/amia/LamontKAL16
Elizabeth Lamont, Nancy Keating, Christopher Azzoli, Mary Beth Landrum:
Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to Cisplatin-Based Doublet Chemotherapy Regimens among a Cohort of Medicare Patients Aged 70 and Older with Stage IV Non-Small Cell Lung Cancer. AMIA 2016

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.